Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Meal delivery study tracks gut bugs in real time

NCT ID NCT04758715

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 65 adults over time to see how their diet, including meals provided by a commercial service, changes the bacteria in their gut. Participants use a food diary and provide samples so researchers can track which microbes increase or decrease after eating certain foods. The goal is to better understand the link between diet and the gut microbiome.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
commercial meal service meals
What this could lead to
If successful, this could help explain how specific foods affect gut bacteria, potentially guiding future dietary recommendations for health.
What could go wrong
This is a small observational study with no treatment or control group, so results may not apply broadly or lead to direct health advice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 65 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2021

Expected to finish

Feb 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * willing to sign consent and have samples collected, * able to read and speak English, * participants must be willing to use an electronic food diary and consume study provided foods, * only individuals able to provide a US address will be included. Exclusion Criteria: * Subjects not able to sign consent on their own accord (ie requiring a Legally Authorized Representative \[LAR\]), * Current parenteral nutrition, * Received cancer treatment within past 6 months prior to signing consent, * Taken antibiotic treatment within the past 1 month prior to signing consent, * Received oral x-ray contrast within the past 1 month prior to signing consent, * Received any type of gastrointestinal bowel preparation in the past 1 month prior to signing consent, * History of organ transplant, * Shellfish allergy, * Insect allergy, * Cacti allergy, * Carmine allergy, * Dragon fruit (pitaya) allergy,

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gastrointestinal tract are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Nebraska - Lincoln

    Lincoln, Nebraska, 68588, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.